» Articles » PMID: 21914043

The Association of Metabolic Syndrome with Reflux Esophagitis: a Case-control Study

Overview
Date 2011 Sep 15
PMID 21914043
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Obesity has been associated with reflux esophagitis. However, the association of metabolic syndrome with reflux esophagitis remains unknown.

Methods: A case-control study of 372 subjects undergoing upper endoscopy during health checkups was conducted (182 patients with reflux esophagitis vs 190 age and gender-matched controls). We further measured their height, weight, waist circumference, hip circumference, blood pressure, triglyceride, high-density lipoprotein, and fasting blood glucose. Multivariable linear regression analysis was used to identify the independent risk factors associated with the presence of reflux esophagitis.

Key Results: Reflux esophagitis cases showed higher mean waist circumference (81.37 ± 0.68 vs 79.36 ± 0.70, P < 0.05), waist hip ratio (0.86 ± 0.01 vs 0.84 ± 0.01, P < 0.05) and fasting blood glucose (5.59 ± 0.10 vs 5.32 ± 0.08, P < 0.05) than those in controls. When adjusted for gender and age, multivariate analysis demonstrated that there was a positive dose-response relationship between reflux esophagitis and waist hip ratio (men: OR 3.41, 95% CI 1.52-7.62, women: OR 3.37, 95% CI 1.61-7.06), triglyceride (OR 2.07, 95% CI 1.12-3.82), fasting blood glucose (OR 1.81, 95% CI 1.12-2.94), and metabolic syndrome (OR 2.01, 95% CI 1.15-3.50), there was an inverse dose-response relationship between reflux esophagitis and high-density lipoprotein for men (OR 0.36, 95% CI 0.15-0.85).

Conclusions & Inferences: High waist hip ratio, triglyceride, fasting blood glucose, and metabolic syndrome were associated with increased risk factors for reflux esophagitis while high high-density lipoprotein for men correlated with a reduced risk of reflux esophagitis.

Citing Articles

Metabolic dysfunction-associated steatotic liver disease and gastroesophageal reflux disease: a mendelian randomization study in European and East Asian populations.

Su C, Liao Z, Li H, Pei Y, Wang Z, Li J Front Genet. 2024; 15:1428334.

PMID: 39703225 PMC: 11655479. DOI: 10.3389/fgene.2024.1428334.


Association between gastroesophageal reflux disease and metabolic syndrome: a bidirectional two-sample Mendelian randomization analysis.

He T, Geng X, Lin X, Li Y, Duan Z Arch Med Sci. 2024; 20(5):1715-1719.

PMID: 39649271 PMC: 11623159. DOI: 10.5114/aoms/193708.


Relationship of different metabolic obesity phenotypes with reflux esophagitis: a propensity score matching analysis.

He T, Wang P, Wang L, Tong M, Duan Z BMC Endocr Disord. 2024; 24(1):239.

PMID: 39506726 PMC: 11542364. DOI: 10.1186/s12902-024-01771-6.


Development and validation of a novel nomogram to predict worsening of gastroesophageal reflux symptoms after laparoscopic sleeve gastrectomy using Lasso-logistic regression.

Jin L, Huang X, Gao Z, Gu J, Zhang Z, Xu F Sci Rep. 2024; 14(1):25427.

PMID: 39455669 PMC: 11511911. DOI: 10.1038/s41598-024-76330-z.


Nomogram for predicting reflux esophagitis with routine metabolic parameters: a retrospective study.

He T, Sun X, Duan Z Arch Med Sci. 2024; 20(4):1089-1100.

PMID: 39439693 PMC: 11493045. DOI: 10.5114/aoms/175536.